Phio Pharmaceuticals Corp... (PHIO)
1.41
-0.02 (-1.40%)
At close: Feb 28, 2025, 3:59 PM
1.39
-1.42%
After-hours: Feb 28, 2025, 07:55 PM EST
Phio Pharmaceuticals Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -10.83M | -11.48M | -13.29M | -8.79M | -8.91M | -7.36M | -12.45M | -8.99M | -10.22M | -8.8M | -20.93M | -12.88M | -10.22M |
| Depreciation & Amortization | 184K | 193K | 75K | 72K | 67K | 81K | 70K | 53K | 77K | 87K | 99K | 147K | 163K |
| Stock-Based Compensation | 303K | 414K | 480K | 136K | 300K | 282K | 314K | 756K | 1.53M | 1.85M | 1.98M | 968K | 2.11M |
| Other Working Capital | -414K | -1.75M | 1.44M | -246K | -472K | -562K | 78K | 680K | 188K | -1M | 539K | 496K | 654K |
| Other Non-Cash Items | 126K | 304K | 117K | 111K | 109K | 405K | 4.71M | -9K | 228K | -10K | 12.25M | 6.18M | -2.36M |
| Deferred Income Tax | n/a | -304K | -233K | n/a | n/a | n/a | -1.62M | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -536K | -1.26M | 990K | -327K | -213K | -523K | -530K | 434K | 1.07M | -881K | 286K | 525K | 317K |
| Operating Cash Flow | -10.75M | -12.13M | -11.86M | -8.8M | -8.64M | -7.52M | -9.51M | -7.76M | -7.32M | -7.76M | -6.31M | -5.06M | -9.99M |
| Capital Expenditures | -5K | -121K | -51K | -19K | -72K | -5K | -203K | -4K | -57K | -95K | -78K | -15K | -59K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 100K | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2M | -8M | -5M | -9M | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.5M | 2.5M | 8M | 6M | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 100K | -150K | -5.5K | 12K | -15K | 31K | -53K |
| Investing Cash Flow | -5K | -121K | -51K | -19K | -72K | -5K | -103K | 5.35M | -5.56M | 2.92M | -3.09M | 16K | -112K |
| Debt Repayment | n/a | n/a | n/a | 204K | -6K | n/a | n/a | n/a | n/a | n/a | -5K | 471K | 383K |
| Common Stock Repurchased | -13K | -28 | n/a | -15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -209K | -4.13M | n/a | n/a | n/a |
| Other Financial Acitivies | -39K | -26K | 2.15M | 3.85M | 69K | n/a | n/a | n/a | 9.7M | n/a | -7K | 17.7M | 3.33M |
| Financial Cash Flow | 7.41M | -26K | 21.72M | 16.13M | 772K | 18.82M | 292K | 10.2M | 9.49M | 1.95M | 15.67M | 9.67M | 3.71M |
| Net Cash Flow | -3.34M | -12.28M | 9.81M | 7.31M | -7.95M | 11.3M | -9.32M | 7.79M | -3.38M | -2.89M | 6.26M | 4.62M | -6.39M |
| Free Cash Flow | -10.75M | -12.25M | -11.91M | -8.82M | -8.72M | -7.53M | -9.72M | -7.76M | -7.37M | -7.85M | -6.39M | -5.08M | -10.05M |